摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(8S,9R,10S)-myrionine | 951681-61-1

中文名称
——
中文别名
——
英文名称
(8S,9R,10S)-myrionine
英文别名
(-)-myrionine;myrionine;1-[[(4aS,8S,8aR)-1,2,3,4,4a,5,6,7,8,8a-decahydroquinolin-8-yl]methyl]piperidin-2-one
(8S,9R,10S)-myrionine化学式
CAS
951681-61-1
化学式
C15H26N2O
mdl
——
分子量
250.384
InChiKey
ARSLSYYPGHBQKL-KCQAQPDRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    411.5±18.0 °C(Predicted)
  • 密度:
    1.034±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (8S,9R,10S)-myrionine三氯氧磷ammonium hydroxide 作用下, 以 甲苯 为溶剂, 反应 12.0h, 以97%的产率得到(-)-myrionidine
    参考文献:
    名称:
    从Myrioneuron nutans合成(-)-甲硫氨酸和(-)-schoberine抗疟疾生物碱的结构和总合成。
    摘要:
    从Myrioneuron nutan(茜草科)及其结构是通过光谱分析(包括质谱和2D NMR)确定的。进行了(-)-myrionidine(1),(-)-schoberine(3),其对映异构体以及9-epimers衍生物的总不对称合成,从而确定了其与Myrionamide(2的绝对构型)的绝对构型)。(-)-Myrionidine(1)及其合成对映异构体(18)对恶性疟原虫具有显着的抗疟活性。
    DOI:
    10.1021/jo801046j
  • 作为产物:
    描述:
    (4 aS,8R,8aR)-8-(hydroxymethyl)decahydroquinoline 在 palladium on activated charcoal 氢气 、 potassium hydride 、 sodium carbonate 、 三乙胺 作用下, 以 二氯甲烷溶剂黄146二甲基亚砜 为溶剂, 反应 16.0h, 生成 (8S,9R,10S)-myrionine
    参考文献:
    名称:
    Solution and Crystal Conformations of Myrionine, a New 8β-Alkyl-cis-decahydroquinoline of Myrioneuron nutans
    摘要:
    Myrionine (1), a new 8 beta-alkyl-cis-decahydroquinoline, was isolated from Myrioneuron nutans. Its structure was determined by spectral methods and then confirmed by X-ray analysis and total synthesis. In solution, 1 gives rise to an N-in/N-out equilibrium. The solvent has weak influence on the N-in/N-out ratio for myrionine (1), whereas together with the anions, it plays an important role for myrionine hydrochloride (9) and hydroiodide (10). The two N-in and N-out conformations obtained separately by crystallization of 9 and 10, respectively, were analyzed by X-ray diffraction.
    DOI:
    10.1021/ol071393a
点击查看最新优质反应信息

文献信息

  • Novel Alkaloids from<i>Myrioneuron nutans</i>
    作者:Van Cuong Pham、Akino Jossang、Thierry Sévenet、Van Hung Nguyen、Bernard Bodo
    DOI:10.1002/ejoc.200801028
    日期:2009.3
    Two new alkaloids, dehydronitraramine (1) and N-formylmyrionine (2) were isolated from the leaves of Myrioneuron nutans, and their structures were determined from spectroscopic analysis, including mass spectrometry and 2D-NMR spectroscopy. The absolute configuration 8S, 9R, 10S of N-formylmyrionine (2) was established by N-formylation of the known (8S,9R,10S)-myrionine and then comparison of the optical
    从 Myrioneuron nutans 的叶子中分离出两种新的生物碱脱氢硝胺 (1) 和 N-甲酰基肉豆碱 (2),并通过光谱分析确定了它们的结构,包括质谱和 2D-​​NMR 光谱。N-甲酰基肉豆蔻氨酸 (2) 的绝对构型 8S、9R、10S 是通过已知 (8S,9R,10S)-肉豆蔻氨酸的 N-甲酰化建立的,然后将天然 N-甲酰基肉豆蔻氨酸 (2) 的旋光度与半合成 (8S,9R,10S)-N-甲酰基肉豆氨酸。Dehydronitraramine (1) 对恶性疟原虫显示出中等的抗疟原虫活性,IC50 值为 16 μM,而 1 和 2 对 KB 细胞显示出较弱的细胞毒性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009 )
  • Structure and Total Synthesis of (−)-Myrionidine and (−)-Schoberine, Antimalarial Alkaloids from <i>Myrioneuron nutans</i>
    作者:Van Cuong Pham、Akino Jossang、Philippe Grellier、Thierry Sévenet、Van Hung Nguyen、Bernard Bodo
    DOI:10.1021/jo801046j
    日期:2008.10.3
    Two new alkaloids, (5S,9S,10R)-myrionidine (1) and (5S,9S,10R,13S)-myrionamide (2), along with the known schoberine (3), were isolated from the leaves of Myrioneuron nutans (Rubiaceae), and their structures were determined from spectral analysis, including mass spectrometry and 2D NMR. The total asymmetric syntheses of (-)-myrionidine (1), (-)-schoberine (3), their enantiomers as well as their 9-epimers
    从Myrioneuron nutan(茜草科)及其结构是通过光谱分析(包括质谱和2D NMR)确定的。进行了(-)-myrionidine(1),(-)-schoberine(3),其对映异构体以及9-epimers衍生物的总不对称合成,从而确定了其与Myrionamide(2的绝对构型)的绝对构型)。(-)-Myrionidine(1)及其合成对映异构体(18)对恶性疟原虫具有显着的抗疟活性。
  • Solution and Crystal Conformations of Myrionine, a New 8β-Alkyl-<i>cis</i>-decahydroquinoline of <i>Myrioneuron nutans</i>
    作者:Van Cuong Pham、Akino Jossang、Angèle Chiaroni、Thierry Sévenet、Van Hung Nguyen、Bernard Bodo
    DOI:10.1021/ol071393a
    日期:2007.8.1
    Myrionine (1), a new 8 beta-alkyl-cis-decahydroquinoline, was isolated from Myrioneuron nutans. Its structure was determined by spectral methods and then confirmed by X-ray analysis and total synthesis. In solution, 1 gives rise to an N-in/N-out equilibrium. The solvent has weak influence on the N-in/N-out ratio for myrionine (1), whereas together with the anions, it plays an important role for myrionine hydrochloride (9) and hydroiodide (10). The two N-in and N-out conformations obtained separately by crystallization of 9 and 10, respectively, were analyzed by X-ray diffraction.
查看更多

同类化合物

锯齿石松宁 箭毒蛙毒素 C 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 2,5-二丙基十氢喹啉 1-(3-氯-丙基)-十氢-喹啉 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 (4aS,5R,8aR)-1-(tert-butoxy)carbonyl-2-oxo-5-(triisopropylsilyloxymethyl)decahydroquinoline trans-(+/-)-1-n-propyl-7-oxodecahydroquinoline 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aβH)-benzo[c]quinolizin-3-one 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aαH)-benzo[c]quinolizin-3-one 3,4,4a,5,6,7,8-heptahydro-8a-hydrodioxy-2(1H)-quinolinone [2-(2,3-dichloro-phenyl)-thiazol-4-yl]-(octahydro-quinolin-1-yl)-methanone (octahydro-quinolin-1-yl)-(2-pyridin-3-yl-thiazol-4-yl)-methanone 2-methylperhydrothiazolo<2,3-j>quinoline 2,4-dichloro-N-[5-((4aRS,8aSR)-octahydroquinoline-1-carbonyl)pyridin-2-yl]benzamide (4aR*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-methylquinoline (4aS*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-(methoxycarbonyl)quinoline (2S,3R,4aS,5R,8aR)-1-(tert-butoxy)carbonyl-3-hydroxy-2-methyl-5-(triisopropylsilyloxymethyl)decahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-5-methylene-2-propyldecahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-2-propyldecahydroquinolin-5-one cis-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid amide lepadin E (+)-lepadin D cis-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 4-methyl-6-(3-methyl-2-thienyl)-4,5,6,7-tetrahydroquinolin-5-one 2,2,4,8-tetramethyldecahydroquinoline 10-oxo-2,5;5,9-diseco-A-dinor-strychnidine-2,5-dioic acid strychnidine-2,3,10-trione 3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one 17a-methyl-3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one methyl 4-oxooctahydroquinoline-1(2H)-carboxylate decahydro-2-oxo-8-quinolinepropanoic acid ethyl ester 1-octahydro[1]quinolyl-propan-2-ol